EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in Lanthanide‐Based Nanoparticle Contrast Agents for MRI and CT : Current Status and Perspectives

Tirusew Tegafaw iD, Endale Mulugeta iD, Ying Liu iD, Xiaoran Chen, Ziyi Lin, Ahrum Baek, Jihyun Kim iD, Yongmin Chang iD, Gang Ho Lee iD

WIREs Nanomedicine and Nanobiotechnology · 2026-11 · 18 (6)

DOI: 10.1002/wnan.70086 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 16.11.2026. Verfasst von Tirusew Tegafaw und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Natural Sciences, Kyungpook National University, Taegu, South Korea. Hauptthemen laut MEDLINE: Contrast Media, Lanthanoid Series Elements, Magnetic Resonance Imaging, Tomography, X-Ray Computed. Die Arbeit nennt 262 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF), National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Magnetic resonance imaging (MRI) and x‐ray computed tomography (CT) are among the most widely utilized diagnostic imaging modalities in clinical practice. MRI offers excellent soft‐tissue contrast without ionizing radiation, whereas CT provides rapid, high‐resolution visualization of anatomical structures based on x‐ray attenuation. Contrast agents (CAs) are used to improve the signal intensity, sensitivity, and therefore, diagnostic accuracy. However, conventional small molecular CAs such as gadolinium (Gd)‐chelates as MRI CAs and iodinated compounds as CT CAs exhibit low sensitivity and short imaging times (i.e., short blood circulation times) owing to their rapid renal clearance. Lanthanide‐based nanoparticles (Ln‐NPs) have emerged as promising alternative CAs to overcome these limitations by providing enhanced sensitivity and longer imaging times. They also provide additional advantages such as drug delivery, reduced dosage, and multimodal imaging capability. This review provides a comprehensive overview of Ln‐NPs tailored for single‐ and dual‐modal imaging in MRI and CT. For MRI applications, we examined Gd, dysprosium (Dy), holmium (Ho), terbium (Tb), and thulium (Tm)‐based NPs, highlighting their roles in T 1 and/or T 2 MRI contrast enhancements. For CT applications, cerium (Ce), Gd, Ho, erbium (Er), Tm, and ytterbium (Yb)‐based NPs were evaluated. In addition, MRI and CT multimodal platforms of Gd, Ho, and Tb‐based NPs, and mixed Gd/Dy and Yb/Gd‐based NPs were discussed. We also discussed in vitro cellular and in vivo toxicities such as histology, body weight changes, biodistribution, clearance, and immunotoxicity. Finally, we addressed the challenges and future perspectives for the development of safe, efficient, and clinically translatable Ln‐NPs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaLanthanoid Series ElementsMagnetic Resonance ImagingTomography, X-Ray ComputedNanoparticlesHumansAnimals

Substanzen

Contrast MediaLanthanoid Series Elements

Autor:innen und Institutionen

  • Department of Chemistry, College of Natural Sciences, Kyungpook National University, Taegu, South Korea.
  • Institute of Biomedical Engineering Research, School of Medicine, Kyungpook National University, Taegu, South Korea.
  • Department of Chemistry Education, Teachers' College, Kyungpook National University, Taegu, South Korea.
  • Department of Molecular Medicine, School of Medicine, Kyungpook National University, Taegu, South Korea.

ORCID-Profile: Tirusew Tegafaw, Endale Mulugeta, Ying Liu, Jihyun Kim, Yongmin Chang, Gang Ho Lee

Förderung

  • National Research Foundation of Korea (NRF)
  • National Research Foundation

Zitieren

APA

Tegafaw, T., Mulugeta, E., Liu, Y., Chen, X., Lin, Z., Baek, A., Kim, J., Chang, Y., & Lee, G. H. (2026). Advances in Lanthanide‐Based Nanoparticle Contrast Agents for MRI and CT : Current Status and Perspectives. WIREs Nanomedicine and Nanobiotechnology, 18(6). https://doi.org/10.1002/wnan.70086

Vancouver

Tegafaw T, Mulugeta E, Liu Y, Chen X, Lin Z, Baek A, et al. Advances in Lanthanide‐Based Nanoparticle Contrast Agents for MRI and CT : Current Status and Perspectives. WIREs Nanomedicine and Nanobiotechnology. 2026;18(6). doi:10.1002/wnan.70086

BibTeX
@article{Tegafaw2026,
  author = {Tegafaw, Tirusew and Mulugeta, Endale and Liu, Ying and Chen, Xiaoran and Lin, Ziyi and Baek, Ahrum and Kim, Jihyun and Chang, Yongmin and Lee, Gang Ho},
  title = {Advances in Lanthanide‐Based Nanoparticle Contrast Agents for MRI and CT : Current Status and Perspectives},
  journal = {WIREs Nanomedicine and Nanobiotechnology},
  year = {2026},
  volume = {18},
  number = {6},
  doi = {10.1002/wnan.70086}
}
Kostenlos starten →